Bone Biologics (BBLG) Total Liabilities (2010 - 2025)

Bone Biologics (BBLG) has 16 years of Total Liabilities data on file, last reported at $418587.0 in Q4 2025.

• Total Liabilities for Q4 2025 came in at $418587.0, up 10.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $418587.0 (up 10.82% YoY), and the FY2025 annual result was $418587.0, up 10.82% from the prior year.
• Total Liabilities climbed to $418587.0 in Q4 2025 per BBLG's latest filing, from $334282.0 in the prior quarter.
• Over five years, Total Liabilities peaked at $15.2 million in Q3 2021 and troughed at $54913.0 in Q1 2022.
• A 5-year average of $2.9 million and a median of $412364.5 in 2025 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities slumped 99.61% in 2022, then soared 7204.93% in 2023.
• A 5-year view of Total Liabilities shows it stood at $99909.0 in 2021, then jumped by 2450.25% to $2.5 million in 2022, then slumped by 67.37% to $831402.0 in 2023, then sank by 54.57% to $377712.0 in 2024, then increased by 10.82% to $418587.0 in 2025.
• Business Quant data shows BBLG's Total Liabilities at $418587.0 in Q4 2025, $334282.0 in Q3 2025, and $406142.0 in Q2 2025.